Inactivation of SARS Coronavirus 2 and COVID-19 patient samples for contemporary immunology and metabolomics studies
D. J. Eddins, L. C. Bassit, J. Chandler, N. S. Haddad, K. Musall, J. Yang, A. Kosters, B. S. Dobosh, M. R. Hernandez, R. P. Ramonell, R. M. Tirouvanziam, F. E.-H. Lee, K. Zandi, R. F. Schinazi, E. Ghosn
This paper demonstrates optimal viral inactivation methods for SARS-CoV-2 and COVID-19 patient samples to enable safe handling at lower biosafety levels while preserving downstream assay fidelity.
bioRxiv · Oct 22, 2021Microbiology